Your browser doesn't support javascript.
loading
Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release.
Schmitt, Veronika; Kesch, Claudia; Jackson, John K; Bidnur, Samir; Beraldi, Eliana; Yago, Virginia; Bowden, Mary; Gleave, Martin E.
Affiliation
  • Schmitt V; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Kesch C; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Jackson JK; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Bidnur S; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Beraldi E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Yago V; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Bowden M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Gleave ME; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Pharm Res ; 37(3): 36, 2020 Jan 21.
Article in En | MEDLINE | ID: mdl-31965346
ABSTRACT

PURPOSE:

We describe the preparation of injectable polymeric paste (IPP) formulations for local and sustained release of drugs. Furthermore, we include the characterization and possible applications of such pastes. Particular attention is paid to characteristics relevant to the successful clinical formulation development, such as viscosity, injectability, degradation, drug release, sterilization, stability performance and pharmacokinetics.

METHODS:

Paste injectability was characterized using measured viscosity and the Hagen-Poiseuille equation to determine injection forces. Drug degradation, release and formulation stability experiments were performed in vitro and drug levels were quantified using HPLC-UV methods. Pharmacokinetic evaluation of sustained-release lidocaine IPPs used five groups of six rats receiving increasing doses subcutaneously. An anti-cancer formulation was evaluated in a subcutaneous tumor xenograft mouse model.

RESULTS:

The viscosity and injectability of IPPs could be controlled by changing the polymeric composition. IPPs demonstrated good long-term stability and tunable drug-release with low systemic exposure in vivo in rats. Preliminary data in a subcutaneous tumor model points to a sustained anticancer effect.

CONCLUSIONS:

These IPPs are tunable platforms for local and sustained delivery of drugs and have potential for further clinical development to treat a number of diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ointments / Drug Carriers / Drug Compounding / Polylactic Acid-Polyglycolic Acid Copolymer Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Pharm Res Year: 2020 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ointments / Drug Carriers / Drug Compounding / Polylactic Acid-Polyglycolic Acid Copolymer Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Pharm Res Year: 2020 Type: Article Affiliation country: Canada